a:5:{s:8:"template";s:9184:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta content="text/html; charset=utf-8" http-equiv="content-type"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed%3A300%2C300i%2C400%2C400i%2C600%2C600i%2C800%2C800i&amp;subset=latin%2Clatin-ext" id="bulk-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}@supports ((position:-webkit-sticky) or (position:sticky)){}p.has-drop-cap:not(:focus)::first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}p.has-drop-cap:not(:focus)::after{content:"";display:table;clear:both;padding-top:14px} @font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:300;src:local('Roboto Condensed Light Italic'),local('RobotoCondensed-LightItalic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVg2ZhZI2eCN5jzbjEETS9weq8-19eDpCEoY9Nc.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:italic;font-weight:400;src:local('Roboto Condensed Italic'),local('RobotoCondensed-Italic'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVj2ZhZI2eCN5jzbjEETS9weq8-19eLAQM4.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:300;src:local('Roboto Condensed Light'),local('RobotoCondensed-Light'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVi2ZhZI2eCN5jzbjEETS9weq8-33mZGCoYag.ttf) format('truetype')}@font-face{font-family:'Roboto Condensed';font-style:normal;font-weight:400;src:local('Roboto Condensed'),local('RobotoCondensed-Regular'),url(https://fonts.gstatic.com/s/robotocondensed/v18/ieVl2ZhZI2eCN5jzbjEETS9weq8-19y7CA.ttf) format('truetype')} /*! normalize.css v3.0.3 | MIT License | github.com/necolas/normalize.css */html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background-color:transparent}a:active,a:hover{outline:0}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}.text-center{text-align:center}ul{margin-top:0;margin-bottom:10px}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.row{margin-left:-15px;margin-right:-15px}.dropdown{position:relative}.dropdown-toggle:focus{outline:0}.nav{margin-bottom:0;padding-left:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-brand{float:left;padding:15px 15px;font-size:18px;line-height:20px;height:50px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}@media (min-width:768px){.navbar-right{float:right!important;margin-right:-15px}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{content:" ";display:table}.container-fluid:after,.container:after,.nav:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}body,html{overflow-x:hidden}body{font-family:'Roboto Condensed',"Helvetica Neue",helvetica,arial,sans-serif;padding:0;color:#404040;font-weight:400;line-height:1.8;font-size:16px;word-wrap:break-word;overflow-x:hidden}a,a:active,a:focus,a:hover{text-decoration:none;color:#0090ff}ul{padding-left:20px}a:active{border-bottom:none}.page-area{padding-top:70px}@media (min-width:768px){.navbar-nav>li>a{padding-top:25px;padding-bottom:25px;transition:all .5s ease-in-out;-moz-transition:all .5s ease-in-out;-webkit-transition:all .5s ease-in-out;-o-transition:all .5s ease-in-out}#site-navigation .container{padding-left:0;padding-right:0}}@media (max-width:767px){.navbar-nav a:focus,.navbar-nav a:hover{color:#fff!important;background-color:#000!important}.menu-container{width:70%;position:absolute;left:0;height:100vh;transform:translate3d(-100%,0,0);overflow-y:auto;overflow-x:auto;background-color:#fff;top:100%}.navbar-brand{padding-right:55px!important}.page-area{left:0;transform:translate3d(0,0,0);transition:transform .5s ease}.navbar-nav{padding:0;margin:0}.navbar-nav a{font-size:14px;padding:12px 10px!important;margin:0!important;line-height:16px!important;float:left!important;margin:0!important;width:100%;text-transform:none!important;word-wrap:break-word;white-space:normal!important}.navbar-nav li{padding:0!important;margin:0!important}}#site-navigation{min-height:70px}.navbar-nav>li>a{border-bottom:0;text-transform:uppercase}.site-title{margin:0;padding:0;font-size:22px;line-height:28px}p.site-description{font-size:13px;line-height:18px;margin:0;-webkit-transition:all .5s ease;transition:all .5s ease}.site-branding-logo{float:left}.site-branding-logo a{border:none;z-index:9999;position:relative}.navbar-brand{padding:10px 15px;height:auto;z-index:99999;position:relative;z-index:1}.navbar{margin-bottom:0}.main-menu{position:relative}.navbar-fixed-top{position:absolute}#site-navigation{background-color:#fff;-webkit-box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);box-shadow:0 10px 20px -12px rgba(0,0,0,.42),0 3px 20px 0 rgba(0,0,0,.12),0 8px 10px -5px rgba(0,0,0,.2);border:none}#site-navigation,nav a{-webkit-transition:all .3s ease;transition:all .3s ease;color:#000}.footer-credits{border-top:1px solid #ccc;padding:15px;clear:both;margin-top:20px;background-color:#fff}</style>
 </head>
<body class="wp-custom-logo" id="blog">
<div class="main-menu">
<nav class="navbar navbar-default navbar-fixed-top" id="site-navigation">
<div class="container">
<div class="navbar-header">
<div class="site-header">
<div class="site-branding-logo">
<a class="custom-logo-link" href="#" itemprop="url" rel="home"></a> </div>
<div class="site-branding-text navbar-brand">
<p class="site-title"><a href="#" rel="home">{{ keyword }}</a></p>
<p class="site-description">
{{ keyword }}</p>
</div>
</div>
</div>
<div class="menu-container"><ul class="nav navbar-nav navbar-right" id="menu-menu-1"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-72 dropdown" id="menu-item-72"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="Projects">Projects</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-73 dropdown" id="menu-item-73"><a class="dropdown-toggle" data-toggle="dropdown" href="#" title="About">About</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-74" id="menu-item-74"><a href="#" title="Contacts">Contacts</a></li>
</ul></div> </div>
</nav>
</div>
<div class="page-area">	
{{ text }}
<br>
<br>
{{ links }}
</div>
<footer class="footer-credits container-fluid row" id="colophon">
<div class="container">
<p class="footer-credits-text text-center">{{ keyword }} 2020</p>
</div>
</footer>
</body>
</html>";s:4:"text";s:11971:"But I also found out that they were looking at bringing in a brain system as well. It will take time to spin up those programs and execute to those. Ladies and gentlemen, at this time, we will now begin the question-and-answer session. But that was kind of. That team really just got put into place at the end of 2018, just starting to get traction and get a pipeline of projects in the first quarter here in 2019. It's just going to take a while. And the fact is, even though we have 140 units or so placed throughout the world. So it disrupts the patient journey. Yes. To summarize, our underlying business and our financial fundamentals remain strong, such that as the market continues to improve, we expect our financial performance will also improve. Good morning, guys. We see continued progress in our ability to regain the full trust of our commercial organization as we move to offense and focus on winning new business. Not because we don't want to divulge it to you, but more than anything, we just don't want to send clear messages to our competition on the level of traction that we are or not getting with that system. In addition, gains from our ongoing cross-currency swap program were particularly strong in the quarter. If the variables that I really just described, continue to play out as they are today, we would expect that sequential improvement seen in Q2 would continue through the back half of 2020, but likely at a more modest pace in Q3, Q4. What I would tell you, just first of all, our strategy is going to be, first and foremost, as we've done better account segmentation, is to focus on what we're defining as platinum accounts. It depends on the customer that you're speaking to. And I kind of break it down probably into two areas. And we really haven’t seen much of a change in demand, I mean, initially, for sure. Thanks, Bryan. There's a lot of investor focus on that. And with that, I’ll turn the call over to Suky to get into more financial details. 2.6%, very consistent with where we've been in 2018 and 2017. More from a, I guess, objective standpoint, we've done a lot of work around our primary focus areas and I truly do believe that that's going to start paying dividends and we're feeling it already. So, we have the opportunity as we scale up to ensure that we have the capacity for all three of the robotic solutions that we provide. And we’ve been very-pleased that our Signature ONE Planner shoulder system continues to gain traction, again, even in Q2. This is Dan. So it's a great development process. Over the past several months, we secured a number of important regulatory clearances for knee, brain, and spine applications for our ROSA platform. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q2 2020 Results Conference Call August  4, 2020  8:30 AM ET, Keri Mattox - SVP, IR and Chief Communications Officer, Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Second Quarter 2020 Earnings Conference Call. That would be an important key message there. That’s all marking [ph] for us, at-market performance in the short-term but transitioning to above market growth with our future robotics launch in this space. I personally have a weekly call with my team to talk about where we are with capacity planning, with the processes and how we're doing relative to certain metrics that we have in place on improving our service levels to customers. Great. We have not had a lot of focus unfortunately over the past few years on cost down, real discipline in margin expansion in our manufacturing facilities because we've been over-indexing on quality remediation, we've been over-indexing on making sure that we have supply. Thanks. Thanks so much. Thank you. Cole Lannum -- Senior Vice President, Investor Relations, and IRO. So, again, my enthusiasm is pretty high probably hearing it. We're going to try to get one more question in even though we're past the bottom of the hour. And that is exactly what is happening. It's one of our major focus areas in the shoulder area and overall set and we're going to continue to focus on it. Thank you very much. And importantly, we continue to see very strong demand for ROSA, even through the pandemic. And our final question comes from Mike Matson with Needham & Company. Joining me virtually today are Bryan Hanson, our President and CEO; and CFO, Suky Upadhyay. But this has been out there for a while, we’re getting very good utilization per unit. Seeing really good uptake with our larger markets, but we’ve got to keep our eyes on the UK, which continues to defer at a very high rate and emerging markets is lacking. In June, we announced with Apple a new application. But I'm excited to see the momentum. And we, as a result of that, want to talk about the virus today. These are both, the initial deferred procedures that we saw in the beginning and the building backlog that’s continuing to happen. In addition to advancing our traditional products and portfolio, at AAOS we also highlighted our integrated ecosystem of solutions. So, what I would say is first of all, I'd like to see all geographies, all businesses improve. The adjusted effective tax rate for the quarter was 17.5%, which is in line with our expectation and full-year guidance range for 2019. All of our businesses are important to us, but they’re not all going to be invested in or managed the same. Another great example of strong innovation and commercial prowess is the Persona Revision story that we’re seeing play out and saw play out in the second floor. Following today’s presentation, there will be a question-and-answer session. And by focusing on these markets, just as I’ve described, we believe that over time, our pursuit of consistent and sustainable mid-single-digits organic growth rates is absolutely possible. So, we’re excited clearly about mymobility, we were before the pandemic, but certainly this is giving us some additional steam in the marketplace. And with that, I'll turn it back to Cole to get into the questions. And with mymobility, what we’re really focusing on is ensuring that we have that patient-physician communication link that’s even better than it was before, but allowing this to happen more virtually. We’ve taken a disciplined and proactive approach to mitigate the earnings impact of the pandemic and enhance our liquidity profile. Zimmer Biomet Holdings, Inc. ZBH is set to report second-quarter 2020 results on Aug 4, before market open. So again, the U.S. is overall trending pretty well, but we’re keeping our eyes on that second surge. Just to repeat that, if the variables that I just described, continue to play out just as they are today, just what we’re seeing today, we would absolutely expect the sequential improvement that we saw in Q2 to continue in the back half, but it would be in a more modest pace. They've -- just across the board. Operator, e're getting close to bottom of the hour. And our adjusted tax rate was 42.8% in the quarter. So, with that, I’m going to turn the call back over to Keri, and I’m looking forward to your questions. In both of these events, it was clear that our sales team is gaining both trust and confidence in their ability to win and in the support they are receiving from the ZB leadership team. Free current stock price quotes and data for Zimmer Biomet Holdings Inc (ZBH). Specific to quality, at Zimmer Biomet everything we do is guided by our commitment to patient safety, quality, and integrity, which is a primary principle of our mission. But the level of work, attention from the senior-level parts of the organization on this demand planning process is probably more aggressive than I've ever seen anywhere for good reason, obviously. Our next question comes from Kyle Rose with Canaccord Genuity. We've got an opportunity to bring a unique solution or a better solution to our patient and to our customer. Remember, though, that all of this is captured in a very clear message that we're sending that, by 2020, we expect all these things to come together and allows us to deliver 2% to 3% which is our weighted average market growth in a consistent way. To give you a sense of the sequential improvement we saw through the second quarter, remember that, on our first quarter call, we noted that, revenues were down about 70% in April across the full business. For example, in some of the hardest hit counties within Texas, we continue to see procedure volumes at 80% or better prior year volumes, see a similar pattern in other severely hit states. And there's this kind of mantra that's going around and it was very heavy a AAOS from our team that this is the year that we prove everybody wrong that doubted that we could return as an organization to where we used to be. Good morning. With that, operator, may we please have the first question? With reference to our optimization of talent and structure, we have made good progress on our goal to become a more agile and results-driven organization. But, when I look at the second quarter numbers and the weighted averages for their market for both [indiscernible] it looks like to me, Zimmer did outperform, declined less than the group averages both worldwide and U.S. specifically. That is probably the most objective measure of whether or not the new culture that we're driving, the One ZB mission and culture is actually gaining traction. One, I think, I’ll just deal from -- your question is, what’s kind of driving the underlying strength of the business, and I’ll give a little more color on that versus what I had in my prepared remarks. And the last piece, when it comes to long-term growth, is our M&A strategy, and this is going to be key for us. What I would tell you is that we still move to a better, more automated process. Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. Then, you turn to the Americas, and this is probably where we saw the biggest and sharpest return in the second quarter, and as Bryan talked about, a little bit ahead of our expectations. We're obviously not going to give 2020 guidance here. So, we’re keeping a close watch on the recovery in that particular market. And as we stated, supply is not a barrier to meeting our financial commitments or stated turnaround time line. I do believe that when you think about the backlog, again, you’ve got to separate it into two different categories. That's the SET business. Importantly, in the U.S., and in other regions and markets, we’re seeing second waves of steep infection growth. After adjusting for the additional day in 2020, June was down 13.5%. But, we do want to share information and insights that may provide shaping of our revenue expectations for the remainder of the year. Bryan, I just wanted to touch on one item here sort of bit strategic. I'm going to provide a quick overview of our first-quarter results, followed by an update on our short-term priorities. I'm excited to see the team in place. So, I’m going to try to tackle this in maybe in two categories. We're going to be flexible based on the business needs or requirements of that customer. Obviously you saw that again at AAOS, ROSA being a big part of that. So, it’s difficult to say that the backlog coming back in is going to give us that tailwind that we want without the negative impacts of those two variables. OK. Rich. Moving to EMEA, the region decreased 49% in the second quarter. There was going to be post-traumatic stress disorder from the commercial organization in this category, and they wouldn’t believe us for a while that it was actually solved, they do now. OK. Even with the performance that they have had, they're happy about it, but they're never satisfied. So, I would say, without giving specifics. And certainly be looking particularly in those accounts where the high share players don't have robotic solutions, that will be the next tier of our focus. ";s:7:"keyword";s:38:"zimmer biomet earnings call transcript";s:5:"links";s:861:"<a href="http://newdestinychurchpc.com/blog/article.php?tag=alyson-hannigan-height-6bb478">Alyson Hannigan Height</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=ring-doorbell-logs-6bb478">Ring Doorbell Logs</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=Andrew-Robertson-fifa-20-6bb478">Andrew Robertson Fifa 20</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=calories-in-pasta-6bb478">Calories In Pasta</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=burn-it-to-the-ground-lyrics-6bb478">Burn It To The Ground Lyrics</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=messi-education-qualification-6bb478">Messi Education Qualification</a>,
<a href="http://newdestinychurchpc.com/blog/article.php?tag=serious-sam-next-encounter-iso-6bb478">Serious Sam Next Encounter Iso</a>,
";s:7:"expired";i:-1;}